Press Release
Canada PFAS Drinking Water Treatment Market Reaches USD 209.8 Million by 2033 Without a Single Provincial Limit
Pheonix Research sizes the Canadian PFAS drinking water treatment market at USD 69.4 million in 2025, rising to USD 209.8 million by 2033
25 October 2026 — Pheonix Research has published a new market report on the treatment of per- and polyfluoroalkyl substances (PFAS) in Canadian drinking water, sizing the market at USD 69.4 million in 2025 and USD 209.8 million by 2033 — a compound annual growth rate of 14.8 per cent — inside a band of USD 106.2 million to USD 305.7 million.
The report’s central finding is that the number which appears to create this market has almost no direct commercial force. Health Canada published an objective of 30 ng/L for the sum of 25 PFAS in August 2024, and no province or territory has written it into a drinking water standard.
| Revenue line | 2025 (USD m) | 2033 (USD m) | Driver |
|---|---|---|---|
| Treatment systems and media | 37.3 | 150.7 | Facilities built, plus recurring media and residuals |
| Analytical testing | 12.0 | 22.2 | Samples at USD 350 each |
| Residential point-of-use / point-of-entry | 11.0 | 24.9 | Certified devices and replacement cartridges |
| Contaminated-site water treatment | 9.0 | 12.0 | Federal liability at defence sites |
| Total | 69.4 | 209.8 | CAGR 14.8% |
The sizing is built bottom-up from facilities rather than top-down from a global total. The universe is 3,342 water treatment facilities (Statistics Canada, Core Public Infrastructure Survey). Against that, the report applies an action rate borrowed from the only regulator that has published one — the US EPA projects that 4,100 to 6,700 of 66,000 public water systems will have to act under its own PFAS rule, or 6.21 to 10.15 per cent — and takes the low end, 208 facilities, at USD 3.0 million of capital and USD 0.11 million a year of operation each.
Health Canada’s objective is a benchmark, not a limit
The 30 ng/L figure replaced two guidelines — PFOS at 600 ng/L and PFOA at 200 ng/L — and nine screening values, collapsing eleven numbers into one group-based sum. It was derived on treatability as much as on toxicology: granular activated carbon, anion exchange and reverse osmosis each remove more than 90 per cent of the PFAS they target at pilot and full scale, and the objective was set to what those processes consistently achieve. Health Canada describes it as “a benchmark for all jurisdictions to strive towards.”
It is enforced nowhere. Québec states that it has no PFAS standard for drinking water, that analysis is not mandatory, and that the federal objective “is not intended as a basis for regulation.” Ontario’s O. Reg. 169/03 carries no PFAS value at all; the province works to an interim advice value of 70 ng/L for the sum of 11 PFAS, which is advice rather than a legal limit. A 14-jurisdiction regulatory tracker lists every Canadian jurisdiction as guidance or advisory, with no adoptions.
“That is the single most important fact in this market, and it governs everything that follows: the trigger is provincial enactment, not the federal number.” — Canada PFAS Drinking Water Treatment Market Report, Size, Share and Forecast 2026–2033
Two defence sites account for 55.7 per cent of one year of the market
Department of National Defence commitments for PFAS at drinking water plants in North Bay, Ontario and Saguenay, Québec total CAD 53.68 million — about USD 38.65 million at a 0.72 planning rate, or 55.7 per cent of the entire 2025 market. The Saguenay commitment for temporary treatment units at La Baie, CAD 45.43 million, is on its own roughly 47 per cent of it.
“The largest single buyer in Canada is not a utility. It is the department that contaminated the water,” the report states. Aqueous film-forming foam used in firefighting is the usual origin of PFAS at defence sites, and the phase-out of PFAS-containing foam runs through Pheonix Research’s global fire protection system market.
PFAS is near-ubiquitous and near-never above the objective
- Québec: PFAS detected in 99.3 per cent of 463 tap water samples from 376 municipalities, at a median total of 2 ng/L, with ten samples from five localities (2.16 per cent) above 30 ng/L.
- British Columbia: the first province-wide assessment, 120 samples, found four above 30 ng/L — 3.33 per cent.
- Saskatchewan: sampling of seven plants in 2023 detected at least one PFAS in every sample and still peaked at 23 ng/L, below the objective.
Because a “below 30 ng/L” result is a report on 25 named substances at whatever detection limit a laboratory uses, the compliance question and the contamination question are not the same question. Analytical testing is the line the objective pays for first: USD 12.0 million in 2025 rising to USD 22.2 million by 2033, at roughly USD 350 a sample.
The build is not the business
Treatment systems and media grow 4.04× across the window, from USD 37.3 million to USD 150.7 million. In 2033 that line splits into USD 128.0 million of capital and USD 22.7 million of recurring media and operating spend — 84.9 per cent build, and 10.8 per cent of the total market. At full build the recurring line converges on the EPA’s own per-system annual cost, roughly USD 58 million across 208 systems. Anyone forecasting this market past 2034 is forecasting replacement media, not construction.
What to watch
One falsifier costs nothing to monitor: the first province to write 30 ng/L into a legally binding drinking water standard. On the report’s low path — no province ever enacts — the 2033 market is USD 106.2 million; on the high path, where most do, it is USD 305.7 million. The band is 95.1 per cent of the base case wide, and the width is regulatory rather than technical.
About the report
Canada PFAS Drinking Water Treatment Market Report, Size, Share and Forecast 2026–2033 is published under Environmental & Sustainability / Water & Wastewater Management. It covers the regulatory position of every Canadian jurisdiction, the bottom-up facility model, the federal liability estate, the technology trade-off between granular activated carbon and anion exchange, the measurement gap between detection and exceedance, and the six questions a buyer should ask a treatment vendor.
Related reading
- Global Wastewater Treatment Market Report, Size & Forecast 2026-2033
- Europe PFAS-Free Food Contact Packaging Market Report, Size & Forecast 2026–2033
- Global Fire Protection System Market Report, Size, Share and Forecast 2026–2033
- Global Biochar Market Report, Size, Share and Forecast 2026–2033
Sources
Health Canada, Objective for Canadian drinking water quality — per- and polyfluoroalkyl substances, 9 August 2024; Statistics Canada, Core Public Infrastructure Survey; Department of National Defence procurement and remediation disclosures for North Bay and Saguenay; US EPA PFAS rule and per-system cost estimates; provincial drinking water sampling programmes in Québec, British Columbia, Saskatchewan and Ontario.
About Pheonix Research
Pheonix Research is a market intelligence platform that queries a live graph of more than 500 market, segment, company and report nodes across 25 industrial sectors, and translates leading signals into role-specific decisions. Its method is bottom-up: primary series and regulator publications first, published figures attributed rather than smoothed, and every forecast stated with the assumption that would break it.